Pursuant to regulations 30 and 34 of SEBI (Listing Obligations and Disclosures Requirement) Regulations 2015, Nectar Lifesciences has informed that it enclosed Annual Report for the financial year 2020-21.
The above information is a part of company’s filings submitted to BSE.